Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
WGS · against 403 other Healthcare companies of similar size
Ranked #290 of 404 · scores higher than 7% of peers
Bars: peers in each 10-point band of the valuation score115 peers with a valuation score of 0–9, including WGS · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | WGS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 392 reported | -5.3% | 1.7% | 23% | 30% | |
| EBITDA yieldHigher is better · 404 reported | -1.6% | 4.3% | 25% | 50% | |
| Free cash flow yieldHigher is better · 196 reported | -3.7% | -0.5% | 36% | 20% | |
| Book yieldHigher is better · 395 reported | 11.9% | 34.6% | 16% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 290 | 1.7B USD | 8 | 31 | |
| 290 | 2.2B USD | 8 | 35 | |
| 290 | 1.9B USD | 8 | 42 | |
| 290 | 2.8B USD | 8 | 51 | |
| 290 | 2.0B USD | 8 | 29 | |
| 290 | 3.7B USD | 8 | 28 | |
| 290 | 2.3B USD | 8 | 27 | |
| 290 | 1.8B USD | 8 | 23 | |
| 290 | 2.5B USD | 8 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score